Krystal Biotech Inc (KRYS)

Net profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 89,159 10,932 -139,975 -69,570 -32,167
Revenue US$ in thousands 296,569 55,764 498 — —
Net profit margin 30.06% 19.60% -28,107.43% — —

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $89,159K ÷ $296,569K
= 30.06%

The net profit margin of Krystal Biotech Inc displayed a significant decrease -28,107.43% at December 31, 2022. However, the margin improved notably to 19.60% at December 31, 2023, indicating a positive turnaround in the company's profitability. By December 31, 2024, the net profit margin rose further to 30.06%, showcasing a continued upward trend and stronger profitability for the company. Although the margin fluctuated, the recent improvements suggest a positive trajectory for Krystal Biotech Inc's financial performance.